Dar Al Dawa Development and Investment
Leadership team data not yet available for this company.
We're expanding our GCC coverage — check back soon.
No announcements yet.
See Data Freshness Monitor for platform-wide data quality.
Insufficient data
0/12 dimensions populated
10/100
85/100
Caution: M-Score elevated
SouqData provides data for informational purposes only. This does not constitute financial advice, a personal recommendation, or an offer to buy or sell any security. Information may contain errors or be outdated. Always verify data independently and consult a licensed financial adviser before making investment decisions.
Get unlimited access to 180+ insight pages, AI copilot, deep research reports, watchlists, portfolio tracking, and the full 210-column screener across 11 MENA exchanges.
| Company | Market cap (USD) | Dividend yield | Governance | Shariah |
|---|---|---|---|---|
| Dar Al Dawa Development and Investment (DARAT) | $14M | — | — | — |
| Middle East Pharmaceutical & Chemical Industries (MPHA · ASE) | — | — | — | — |
| Arab Center for Pharmaceutical & Chemical Industries (APHC · ASE) | — | — | — | — |
| Hikma Pharmaceuticals PLC (HITS · ASE) | — | — | 42(D) | — |
| Meditera Tibbi Malzeme Sanayi Ve Ticaret A.S. (MEDTR · BIST) | $95M | — | — | — |
| Lokman Hekim Engurusag Saglik, Turizm, Egitim Hizmetleri ve Insaat Taahhut A.S. (LKMNH · BIST) | $94M | — | — | — |
Auto-generated peer set — same GICS sector, comparable market-cap band. Governance score is the unified 8-factor model (independence, board size, CEO/chair separation, attendance, auditor, credentials, committees, pay transparency). Shariah uses AAOIFI Standard No. 21. View all 58 sector peers.
